scholarly journals VEGF involvement in psoriasis

2015 ◽  
Vol 88 (3) ◽  
pp. 247-252 ◽  
Author(s):  
Mihaela Elena Marina ◽  
Iulia Ioana Roman ◽  
Anne-Marie Constantin ◽  
Carmen Mihaela Mihu ◽  
Alexandru Dumitru Tătaru
Keyword(s):  
Endothelial Cells ◽  
Growth Factor ◽  
Vascular Endothelial Cells ◽  
Cell Types ◽  
Vascular Endothelial ◽  
Hematopoietic Stem ◽  
Promising Target ◽  
Vegf Pathway ◽  
Endothelial Growth Factor

Vascular endothelial growth factor (VEGF) is a key growth factor, regulating the neovascularization, during embryogenesis, skeletal growth, reproductive functions and pathological processes. The VEGF receptors (VEGFR) are present in endothelial cells and other cell types, such as vascular smooth muscle cells, hematopoietic stem cells, monocytes, neurons, macrophages, and platelets.Angiogenesis is initiated by the activation of vascular endothelial cells through several factors. The excess dermal vascularity and VEGF production are markers of psoriasis.The pathological role of VEGF/VEGFR signaling during the psoriasis onset and evolution makes it a promising target for the treatment of psoriasis. Antibodies and other types of molecules targeting the VEGF pathway are currently evaluated in arresting the evolution of psoriasis.

VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B

2009 ◽  
Vol 297 (5) ◽  
pp. H1685-H1696 ◽  
Author(s):  
Mitsuho Onimaru ◽  
Yoshikazu Yonemitsu ◽  
Takaaki Fujii ◽  
Mitsugu Tanii ◽  
Toshiaki Nakano ◽  
...  
Keyword(s):  
Endothelial Cells ◽  
Growth Factor ◽  
Vascular Endothelial Cells ◽  
Neutralizing Antibody ◽  
Vascular Endothelial ◽  
Mural Cell ◽  
Mural Cells ◽  
Type 3 ◽  
Endothelial Growth Factor ◽  
Capillary Stability

Emerging evidence indicates that the tight communication between vascular endothelial cells and mural cells using platelet-derived growth factor (PDGF)-BB is essential for capillary stabilization during the angiogenic process. However, little is known about the related regulator that determines PDGF-BB expression. Using murine models of therapeutic neovascularization, we here show that a typical lymphangiogenic factor, vascular endothelial growth factor (VEGF)-C, is an essential regulator determining PDGF-BB expression for vascular stabilization via a paracrine mode of action. The blockade of VEGF type 3 receptor (VEGFR3) using neutralizing antibody AFL-4 abrogated FGF-2-mediated limb salvage and blood flow recovery in severely ischemic hindlimb. Interestingly, inhibition of VEGFR3 activity not only diminished lymphangiogenesis, but induced marked dilatation of capillary vessels, showing mural cell dissociation. In these mice, VEGF-C and PDGF-B were upregulated in the later phase after induced ischemia, on day 7, when exogenous FGF-2 expression had already declined, and blockade of VEGFR3 or PDGF-BB activities diminished PDGF-B or VEGF-C expression, respectively. These results clearly indicate that VEGF-C is a critical mediator, not only for lymphangiogenesis, but also for capillary stabilization, the essential molecular mechanism of communication between endothelial cells and mural cells during neovascularization.

Sign in / Sign up

Export Citation Format

Share Document